RCA
ABBV icon

Roberts Capital Advisors’s AbbVie ABBV Stock Holding History

Roberts Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,597
Closed -$1.04M – 64
2025
Q2 		$1.04M Sell
5,597
-135
-2% -$25.1K 0.77% 32
2025
Q1 		$1.2M Hold
5,732
– – 1.05% 22
2024
Q4 		$1.02M Hold
5,732
– – 0.85% 30
2024
Q3 		$1.13M Hold
5,732
– – 0.97% 22
2024
Q2 		$1.04M Hold
5,732
– – 1% 22
2024
Q1 		$1.04M Buy
+5,732
New +$988K 1% 22
2022
Q3 		$825K Hold
6,145
– – 1.2% 19
2022
Q2 		$941K Hold
6,145
– – 1.29% 15
2022
Q1 		$996K Hold
6,145
– – 1.03% 17
2021
Q4 		$832K Buy
+6,145
New +$726K 0.78% 46

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Roberts Capital Advisors's ABBV Position: Q3 2025 in Review

Roberts Capital Advisors sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 5,597 shares — an estimated $1.04M sold.

Roberts Capital Advisors first reported a position in ABBV in Q4 2021 and held it in 10 quarters. The position peaked at $1.2M in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Roberts Capital Advisors reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Roberts Capital Advisors sold 5,597 AbbVie shares in Q3 2025, an estimated $1.04M.
  • Roberts Capital Advisors first reported a position in AbbVie in Q4 2021 and held it in 10 quarters.
  • Roberts Capital Advisors's AbbVie position peaked at $1.2M in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Roberts Capital Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.